Overview

Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers

Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
Whether pantoprazole versus famotidine for the prevention of recurrent peptic ulcers in thienopyridine users remains unclear.
Phase:
N/A
Details
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Treatments:
Famotidine
Histamine
Histamine H2 Antagonists
Histamine phosphate
Pantoprazole
Proton Pump Inhibitors